Headspace Volatile Organic Compound (VOC) Profiling of Infected and Non-Infected Wound Swabs—A Pilot Study
Authors:
- Shane FitzgeraldSFShane Fitzgerald
- Linda HollandLHLinda Holland
- Melissa FinneganMFMelissa Finnegan
- Kellie FortuneKFKellie Fortune
- Brid CooneyBCBrid Cooney
- Eoghan O’NeillEOEoghan O’Neill
- John H. McDermottJMJohn H. McDermott
- Seamus SreenanSSSeamus Sreenan
- Tommy Kyaw-TunTKTommy Kyaw-Tun
- Aoife MorrinAMAoife Morrin
Open Access
- 24 April 2026
- journal article
- research article
- Published by MDPI AG in Biomolecules
- Vol. 16 (5) , 634
Abstract
Infections of chronic wounds are a major healthcare burden worldwide and can lead to poor health outcomes such as amputations of limbs and death. Detecting infections early significantly increases the effectiveness of therapeutic interventions. Screening of volatile organic compounds (VOCs) emitted from wound swab samples can potentially serve as a highly specific indicator of infection. Profiling of VOCs from infected and non-infected wounds was carried out. Swab samples were collected from 26 wounds from 23 patients (n = 20 diabetic patients; n = 3 non-diabetic patients). There were 16 wounds sampled that were clinically determined as infected, and 10 as non-infected. Headspace-solid phase microextraction gas chromatography-mass spectrometry (HS-GC-MS) was used to rapidly sample and detect VOCs from the swabs following a short incubation period. A total of 42 compounds were identified and included for analysis. Infected wounds emitted more diverse VOCs compared to non-infected wounds. Higher numbers of compounds with significantly higher abundances were detected from severely infected wounds compared to less severely infected wounds. Abundances of short-chain fatty acids (SCFAs) and branched-chain fatty acids (BCFAs) were found to be the strongest discriminators of infected from non-infected wounds. Further validation is needed, but the results of this pilot study highlight the potential of detecting these compounds as a highly specific and targeted route to predicting or detecting wound infections in the future.Keywords
Funding Information
- Science Foundation Ireland (SFI/12/RC/2289_P2)
- European Regional Development Fund and by the SFI Insight Research Centre for Data Analytics
This publication has 34 references indexed in Scilit:
- Applications of mass spectrometry in the routine diagnostic medical laboratory – a status report 2025Journal of Chromatography B, 2026
- Volatile organic compounds (VOCs) detection for the identification of bacterial infections in clinical wound samplesTalanta, 2025
- Volatilomes of human infectionAnalytical and Bioanalytical Chemistry, 2023
- Wound irrigation versus swabbing technique for cleansing noninfected chronic wounds: A systematic review of differences in bleeding, pain, infection, exudate, and necrotic tissueJournal of Tissue Viability, 2022
- Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update)Diabetes/Metabolism Research and Reviews, 2020
- Differentiation between infected and non-infected wounds using an electronic noseClinical Microbiology and Infection, 2019
- Strain- and Species-Level Variation in the Microbiome of Diabetic Wounds Is Associated with Clinical Outcomes and Therapeutic EfficacyCell Host & Microbe, 2019
- Diagnosis of pulmonary tuberculosis and assessment of treatment response through analyses of volatile compound patterns in exhaled breath samplesJournal of Infection, 2017
- Are pathogenic bacteria just looking for food? Metabolism and microbial pathogenesisTrends in Microbiology, 2011
- Formation of volatile sulfur compounds and metabolism of methionine and other sulfur compounds in fermented foodApplied Microbiology and Biotechnology, 2008